Decitabine-cedazuridine in patients with MDS and TP53 mutations

Authors

• Samuel Urrutia, Washington University School of Medicine in St. Louis
• Koji Sasaki, University of Texas MD Anderson Cancer Center
• Alex Bataller, University of Texas MD Anderson Cancer Center
• Hagop Kantarjian, University of Texas MD Anderson Cancer Center
• Guillermo Montalban-Bravo, University of Texas MD Anderson Cancer Center
• James McCloskey, Hackensack University
• Elizabeth A Griffiths, Roswell Park Comprehensive Cancer Center
• Karen Yee, Princess Margaret Cancer Centre
• Amer Zeidan, Yale University
• Michael Savona, Vanderbilt University
• Aram Oganesian, Taiho Oncology, Inc
• Yuri Sano, Taiho Oncology, Inc
• Harold N Keer, Taiho Oncology, Inc
• Guillermo Garcia-Manero, University of Texas MD Anderson Cancer Center

Journal

Blood Advances

Publication Date

2-10-2026

Volume

10

Issue

3

First Page

881

Last Page

886

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2025017745

Rights and Permissions

Urrutia S, Sasaki K, Bataller A, Kantarjian H, Montalban-Bravo G, McCloskey J, Griffiths EA, Yee K, Zeidan A, Savona M, Oganesian A, Sano Y, Keer HN, Garcia-Manero G. Decitabine-cedazuridine in patients with MDS and TP53 mutations. Blood Adv. 2026 Feb 10;10(3):881-886. doi: 10.1182/bloodadvances.2025017745. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Urrutia, Samuel; Sasaki, Koji; Bataller, Alex; Kantarjian, Hagop; Montalban-Bravo, Guillermo; McCloskey, James; Griffiths, Elizabeth A; Yee, Karen; Zeidan, Amer; Savona, Michael; Oganesian, Aram; Sano, Yuri; Keer, Harold N; and Garcia-Manero, Guillermo, "Decitabine-cedazuridine in patients with MDS and TP53 mutations." Blood Advances. 10, 3. 881 - 886. (2026).
https://digitalcommons.wustl.edu/oa_4/6503

Additional Links

Supplemental material is available for this article at publisher site.